Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-12-20
DOI
10.3389/fphar.2019.01462
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia
- (2019) Anton JM Loonen et al. PHARMACOGENOMICS
- Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients
- (2019) Taichi Ochi et al. JOURNAL OF AFFECTIVE DISORDERS
- The central serotonin 2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research
- (2018) Céline Devroye et al. PHARMACOLOGY & THERAPEUTICS
- Association of Polymorphisms of Serotonin Transporter (5HTTLPR) and 5-HT2C Receptor Genes with Criminal Behavior in Russian Criminal Offenders
- (2017) Valentina A. Toshchakova et al. NEUROPSYCHOBIOLOGY
- The role of 5-HT receptors in depression
- (2017) Christine N. Yohn et al. Molecular Brain
- Circuits Regulating Pleasure and Happiness—Mechanisms of Depression
- (2016) Anton J. M. Loonen et al. Frontiers in Human Neuroscience
- 5-HT2C receptors in psychiatric disorders: A review
- (2016) A. Chagraoui et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia
- (2016) Svetlana A. Ivanova et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015
- (2015) Michael Bauer et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties
- (2014) B Guardiola-Lemaitre et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuronal localization of the 5-HT2 receptor family in the amygdaloid complex
- (2014) Cristiano Bombardi Frontiers in Pharmacology
- The Epidemiology of Depression Across Cultures
- (2013) Ronald C. Kessler et al. Annual Review of Public Health
- Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms
- (2013) Gavin P. Reynolds et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists
- (2013) Guy A. Higgins et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders
- (2013) Michael Bauer et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Genetics in psychiatry: Are the promises met?
- (2011) Brigitta Bondy WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started